Vacuum system for a prosthetic foot

Information

  • Patent Grant
  • 10842653
  • Patent Number
    10,842,653
  • Date Filed
    Friday, August 24, 2018
    5 years ago
  • Date Issued
    Tuesday, November 24, 2020
    3 years ago
Abstract
A prosthetic foot comprising a vacuum system configured to attach to a vacuum attachment apparatus and a residual limb. The prosthetic foot may comprise a resilient bottom member, a resilient top member, and a vacuum system. The resilient bottom member may comprise a front end and a rear end. The resilient top member may comprise a front end and a rear end and the front end of the resilient top member may be connected to the front end of the resilient bottom member. The vacuum system may be coupled to an underside of the rear end of the top member. The vacuum system may comprise a compressible member, a chamber located within the compressible member, a valve system received within the compressible member, a passageway connecting the valve system and the chamber, and an air return coupled to the valve system and the vacuum attachment apparatus.
Description
BACKGROUND

Prosthetic feet are well known in the art. In use, such prosthetic feet are typically mounted to either an above knee amputation socket or a below knee amputation socket and are designed to mimic the natural gait of a user. Traditionally, the sockets of most amputation types are retained on the user through friction. This friction has been achieved by using socks or liners of various specialized materials. The major drawback with this system has been that over the course of a day, the amputated limb will change its volume, and the friction force will change accordingly. Replacing the friction retention system with a vacuum retention system has proven to be advantageous to the user for many reasons. The biggest reason being that vacuum helps the limb volume to remain more stable which improves socket retention and limb health. Additionally, vacuum systems for prosthetic feet may be provided to further enhance the feel, fit, and function of the foot to the user for all types of lower limb amputation (e.g. above knee, below knee, etc.). Problems exist with vacuum systems including the noise of the electric motor and vacuum pump being disturbing to the user and those nearby and high maintenance requirements due to the complexity of the vacuum system.


SUMMARY

An exemplary vacuum system for a prosthetic foot may comprise a compressible member, a chamber located within the compressible member, and a valve system that connects to the prosthetic socket of the user. The valve system may comprise a valve housing, a pair of valves, an exhaust port, a fitting, an air passageway, and an air return.


Furthermore, the prosthetic foot may comprise a resilient bottom member having a first bottom end and a second bottom end, a resilient top member having a first top end and a second top end, wherein the first top end is connected to the first bottom end of the resilient bottom member, and wherein the resilient top member is connected to a mounting bracket and positioned over the resilient bottom member and directed towards the back of the prosthetic foot.





BRIEF DESCRIPTION OF THE DRAWINGS

A more complete understanding of the present invention may be derived by referring to the detailed description and claims when considered in connection with the following illustrative figures. In the following figures, like reference numbers refer to similar elements and steps throughout the figures.


Elements and steps in the figures are illustrated for simplicity and clarity and have not necessarily been rendered according to any particular sequence. For example, steps that may be performed concurrently or in a different order are illustrated in the figures to help to improve understanding of embodiments of the present technology.


The figures described are for illustration purposes only and are not intended to limit the scope of the present disclosure in any way. Various aspects of the present invention may be more fully understood from the detailed description and the accompanying drawing figures, wherein:



FIG. 1 is a perspective view representatively illustrating a vacuum system on a prosthetic foot in accordance with exemplary embodiments of the present technology;



FIG. 2 is a rear view representatively illustrating the vacuum system on a prosthetic foot in accordance with exemplary embodiments of the present technology;



FIG. 3 is a side view representatively illustrating the vacuum system on a prosthetic foot in accordance with exemplary embodiments of the present technology;



FIG. 4 is a side, cross section view along the line A-A representatively illustrating the vacuum system on a prosthetic foot in accordance with exemplary embodiments of the present technology;



FIG. 5 is a partial rear, cross section view along the line B-B representatively illustrating the vacuum system on a prosthetic foot in accordance with exemplary embodiments of the present technology



FIG. 6 is a perspective view of a compressible member with a heel member and a top insert in accordance with exemplary embodiments of the present technology;



FIG. 7 is a rear view of the compressible member with the heel member and the top insert in accordance with exemplary embodiments of the present technology;



FIG. 8 is a side view of the compressible member with the heel member and the top insert in accordance with exemplary embodiments of the present technology;



FIG. 9 is a perspective view of the heel member of the compressible member in accordance with exemplary embodiments of the present technology;



FIG. 10 is a perspective view of the top insert of the compressible member in accordance with exemplary embodiments of the present technology;



FIG. 11 is a side view of the top insert of the compressible member in accordance with exemplary embodiments of the present technology;



FIG. 12 is a rear view of the top insert of the compressible member in accordance with exemplary embodiments of the present technology;



FIG. 13 is a bottom view of the top insert of the compressible member in accordance with exemplary embodiments of the present technology;



FIGS. 14A-D show various view of a valve housing in accordance with exemplary embodiments of the present technology;



FIG. 15 is a perspective view of an additional embodiment of a compressible member with a heel member and a side insert in accordance with exemplary embodiments of the present technology;



FIG. 16 is a side view of the additional embodiment of the compressible member with the heel member with the side insert removed in accordance with exemplary embodiments of the present technology;



FIG. 17 is a bottom view of the additional embodiment of the compressible member with the heel member and the side insert in accordance with exemplary embodiments of the present technology;



FIG. 18 is a rear view of the additional embodiment of the compressible member with the heel member and the side insert in accordance with exemplary embodiments of the present technology;



FIG. 19 is a perspective view of the side insert of the compressible member in accordance with exemplary embodiments of the present technology;



FIG. 20 is a side view of the side insert of the compressible member in accordance with exemplary embodiments of the present technology;



FIG. 21 is a rear view of the side insert of the compressible member in accordance with exemplary embodiments of the present technology;



FIG. 22 is a perspective view of an additional embodiment of a compressible member in accordance with exemplary embodiments of the present technology;



FIG. 23 is a rear view of the additional embodiment of the compressible member in accordance with exemplary embodiments of the present technology; and



FIG. 24 is a side view of the additional embodiment of the compressible member in accordance with exemplary embodiments of the present technology.





DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS

The present technology may be described in terms of functional block components and various processing steps. Such functional blocks may be realized by any number of components configured to perform the specified functions and achieve the various results. For example, the present technology may be used with a prosthetic foot for various amputation types (above knee, below knee, etc.) In addition, the present technology may be practiced in conjunction with any number of materials and methods of manufacture and the system described is merely one exemplary application for the technology.


While exemplary embodiments are described herein in sufficient detail to enable those skilled in the art to practice the invention, it should be understood that other embodiments may be realized and that logical structural, material, and mechanical changes may be made without departing from the spirit and scope of the invention. This disclosure, its aspects and implementations, are not limited to the specific components or assembly procedures disclosed herein. Many additional components and assembly procedures known in the art consistent with the intended apparatus will become apparent for use with implementations of vacuum systems for prosthetic feet. Thus, the following descriptions are not intended as a limitation on the use or applicability of the invention, but instead, are provided merely to enable a full and complete description of exemplary embodiments.


Briefly, in accordance with exemplary embodiments, a vacuum system for a prosthetic foot is illustrated, which allows for a more comfortable fit of the residual limb to the prosthetic socket of a user. Additionally, studies have shown that elevated vacuum above a certain level is beneficial for residual limb health and maintaining residual limb volume.


A typical prosthetic foot stores energy during the gait cycle and transfers the return potential energy in order to “put a spring in your step.” The roll through of a prosthetic foot is defined in the gait cycle as the process from the heel-strike phase to the mid-stance phase to the toe-off phase. The heel-strike phase begins when the heel, or rear portion of the foot touches the ground, and includes the loading response on the foot. The mid-stance phase is when the foot is flat on the ground and the body's center of gravity is over the foot. The toe-off phase is the finish of the stance phase and ends when the tip of the foot is the only portion in contact with the ground, and the load is entirely on the toe/tip of the foot. This is just prior to the swing phase, which constitutes the other half of the gait cycle.


As the user moves through the stance phase portion of the gait cycle the tibia portion of the leg, or that section of the leg defined below the knee, rotates through in relation to the ground. If the mid-stance phase is defined as the lower leg at 90 degrees to the ground, then looking at the side view of an individual, the angle of the lower leg at the heel-strike phase may occur at approximately 65 degrees and the angle of the lower leg at the toe-off phase may occur at approximately 110 degrees. The rotation of the lower leg on the theoretical ankle is notated as tibial progression or lower leg progression during the stance phase. It is through the loads imparted by a user to a prosthetic foot through the stance phase of the gait cycle that a vacuum system may be powered to provide a better fit and feel for the connection of the residual limb of the user and the prosthetic socket throughout the gait cycle.


In accordance with various embodiments and with reference to FIGS. 1-7, a vacuum system 100 for a prosthetic foot 102 is shown. The prosthetic foot 102 may comprise a resilient bottom member 104, a resilient top member 106, a connection point 108 attached to the top member 106 and configured for attachment to a user, and a compressible member 110. The resilient bottom member 104 may have a front end 112 and a rear end 114. The resilient top member 106 may have a front end 116 and a rear top end 118. Further, the front end 112 of the resilient top member 106 can be connected to the front end 116 of the resilient bottom member 104, while the resilient top member 106 can be positioned over the resilient bottom member 104 and directed towards the rear of the prosthetic foot 102.


The connection point 108 may be coupled to the rear top end 118 of the resilient top member and comprise a mounting portion 120. The mounting portion 120 may comprise a spherical dome and an attachment portion, which is a standard male pyramid adapter used in the prosthetic industry. The pyramid adapter may be coupled with a standard receiver used in the practice of prosthetics, for example, a Staats style attachment, which is commonly known in the prosthetic industry. The mounting portion 120 may use a standard receiver adapter, as understood by one of ordinary skill in the art. According to various embodiments the mounting portion 120 may facilitate attachment to the residual limb of the user. The mounting portion 120 may comprise a centerline that is aligned with the weight line of the user.


Moreover and with renewed reference to FIG. 1, the top member 106, bottom member 104, and compressible member 110 transfer energy between themselves in a natural, true foot manner. The loading response during the heel strike phase compresses compressible member 110 and top member 106, which in turn passes energy into, and causes a deflection of, a rear portion of bottom member 104. Energy is transferred towards the front of prosthetic foot 100 during the mid-stance phase. Furthermore, an upward deflection of at least one of bottom member 104 and top member 106 stores energy during the transition from the mid-stance phase to the toe-off phase of the gait cycle.


With respect to the walking motion, the prosthetic foot 102 is configured to increase the surface-to-foot contact through the gait cycle. The increased surface contact allows for a smoother gait cycle, and increases stability in comparison to the typical prior art prosthetics. In exemplary embodiments, the underside of bottom member 104 has different contours that provide increased surface contact for different types of uses.


The resilient bottom member 104 of the prosthetic foot 102 can have various shapes depending on desired use. The desired use may include prosthetic feet for above-knee amputees or prosthetic feet for below-knee amputees. In various embodiments, the prosthetic foot 102 for above-knee amputees may comprise a bottom member 104 having a curved bottom with no inflection point. In one embodiment, the prosthetic foot 102 comprises a resilient bottom member 104 having a partially curved portion from the front end 112 to the rear end 114 of the resilient bottom member 104. In various embodiments, the bottom member 104 may comprise a constant arc due to single radius forming the partial curve of the bottom member 104. In other various embodiments, the curve of the bottom member 104 can be designed as a spline of variable radii. The curve of bottom member 104 in above-knee prosthetic foot facilitates keeping an artificial knee stable because the forces substantially restrict the knee from bending. The curved bottom member 104 enables a rocking motion even if the artificial knee is hyper-extended.


Similarly, the prosthetic foot 102 for below-knee amputees may comprises a bottom member 104 having a partially curved front portion and a substantially linear rear portion. In one embodiment, the prosthetic foot 102 comprises a resilient bottom member 104 having a partially curved portion from the front end 112 to a middle portion 122 and a substantially linear portion from the middle portion 122 to the rear end 114 of the resilient bottom member 104. The front portion from the front end 112 to the middle portion 122 of resilient bottom member 104 may have a constant arc due to single radius forming the partial curve. In various embodiments, the front portion from the front end 112 to the middle portion 122 of resilient bottom member 104 can have a curve designed as a spline of variable radii. In accordance with various embodiments, the rear portion from the middle portion 122 to the rear end 114 of the resilient bottom member 104 can be substantially straight and tangent to the front portion such that bottom member 104 does not have an inflection point. A straight rear portion and a curved front portion of bottom member 104 facilitates rotation of the tibia progressing the natural rotation of the knee forward and preventing hyper-extension of the knee.


In accordance with an exemplary embodiment, resilient bottom and top members 104, 106 may be made of glass fiber composite. The glass fiber composite may be a glass reinforced unidirectional fiber composite. In one embodiment, the fiber composite material is made of multiple layers of unidirectional fibers and resin to produce a strong and flexible material. The fibers may be glass fibers or carbon fibers. Specifically, layers of fiber are impregnated with the resin, and a glass reinforcement layer can be positioned between at least two fiber weave layers. Typically, several layers of the unidirectional fibers or tape are layered together to achieve the desired strength and flexibility. Further, in various embodiments the layers of unidirectional fibers or tape can be oriented at various angles.


The vacuum system 100 may be used with any conventional prosthetic leg (consisting of socket, pylon, etc.). The vacuum system 100 may be configured to connect to any commercially available prosthetic socket designed to work with a vacuum attachment apparatus. Specifically, the vacuum system 100 will connect to an elevated vacuum suspension setup and also should also work with any commercially available prosthetic socket designed for passive suction suspension.


In one embodiment, the vacuum system 100 may be utilized with the existing compressible member 110. In another embodiment, the vacuum system may be added to a foot without a compressible member or used in conjunction with an existing compressible member in a prosthetic foot.


Referring to FIGS. 5-8, the vacuum system 100 for a prosthetic foot may comprise a compressible member 110, a chamber 124 located within the compressible member 110, and a valve system 126 that connects to the prosthetic socket of the user (not shown).


The compressible member 110 may comprise a heel member 128 and a top plug insert 130. In various embodiments, the top plug insert 130 and the heel member 128 can be any suitable shape as contemplated by one of ordinary skill in the art. In various embodiments, the top plug insert 130 may be inserted within the heel member 128 to form the chamber. As shown in FIG. 9, the heel member 128 may comprise a pair of sidewalls 132, 134 with internal bores 136, 138, a front wall 133, a rear wall 135, and a cavity 140 that receives the top plug insert 130. The cavity 140 may comprise an internal surface 142 or any other suitable shape.


Referring now to FIGS. 6, 7, and 10, the top plug insert 130 may comprise an internal bore 144 and a void 146 that function as an air passageway 148. The top plug insert 130 may comprise a concave lower surface 150. When the top plug insert 130 is placed within the cavity 140 the internal bores 136, 138 of heel member 128 align with the internal bore 144 of the top plug insert 130 to receive the valve system 126, shown in FIG. 5. Additionally, the concave internal surface 142 of the cavity 140 and the concave lower surface 150 of the top plug insert 130 form the chamber 124. In various embodiments, the chamber 124 may be generally in the shape of an oblate spheroid, a short or flattened octahedron, a rectangular pillow shape, or any other shape that can be collapsed on itself when a vertical force is applied.


The top plug insert 130 is both bonded in place and mechanically locked by the valve system 126 which protrudes through the internal bores 136, 138 of heel member 128 and the internal bore 144 of the top plug insert 130. The top plug insert 130 may be bonded to the heel member 128 using an adhesive appropriate for bonding two elastomeric deformable materials, such as rubber, together. In various embodiments, the top plug insert 130 and the cavity 140 within the heel member 128 can be any suitable shape as contemplated by one of ordinary skill in the art as long as the top plug insert 130 is capable of being inserted within the cavity 140 within the heel member 128 to create the chamber 124.


In various embodiments, the chamber 124 may be located within the compressible member 110 and is connected to the valve system 126 by the air passageway 148. In one embodiment, the chamber 124 may be formed between the internal surface 142 of the heel member 128 and the lower surface 150 of the top plug insert 130. In one embodiment, chamber 124 may comprise a generally rectangular in shape as shown in FIG. 6. When viewed from the rear, as shown in FIGS. 5 and 7, the chamber 124 is roughly elliptical in shape, which allows the chamber to fully collapse when loaded. In another embodiment, the chamber 124 is generally rectangular when viewed from the side and from the back. In another embodiment chamber 124 may comprise an upside-down T shape when viewed from the side. In one embodiment the volume of chamber 124 is approximately 0.1 to 0.25 cubic inches. It should be understood that any volume contemplated may be used as long as the volume is configured to provide enough back pressure to seal the socket to the residual limb.


The chamber 124 may be connected to the valve system 126 by way of air passageway 148. In various embodiments, the air passageway 148 can be a void in the top plug insert 130 or a separate tube located inside the top plug insert 130. The separate tube comprising air passageway 148 may be a small diameter stainless steel tubing, or small diameter carbon fiber tubing, small diameter flexible plastic tubing, and the like. Alternatively, air passageway 148 may connect chamber 124 to the valve system 126 in a way external to compressible member 110.


It should be noted that in an exemplary embodiment, that there is a single air passageway 148 connecting the chamber 124 to the valve system 126. In various embodiments the air passageway 148 may be bi-directional. Furthermore, the chamber 124 contemplated above may exist solely between the internal surface 142 of the heel member 128 and the lower surface 150 of the top plug insert 130 and may be any suitable shape that can compress and/or collapse on itself. Specifically, in one embodiment, there is not any contemplated internal membrane located within the chamber 124 between the internal surface 142 of the heel member 128 and the lower surface 150 of the top plug insert 130.


In various embodiments and referring now to FIGS. 5-7, the valve system 126 may comprise a valve housing 152 and an air return 154. The valve housing 152 may comprise a pair of valves 156, 158, an exhaust port 160, and a fitting 162. An air chamber 164 connects the pair of valves 156, 158 and allows for air to travel therebetween. A valve housing passageway 165 connects the passageway 148 to the air chamber 164. Air may travel into the housing through valve 156 and out through valve 158. The air return 154 connects to the prosthetic socket of the user, which contains the vacuum attachment apparatus. The air return 154 may comprise standard ⅛ inch diameter tubing used to connect vacuum systems to prosthetic sockets.


In various embodiments, the valve housing 152 may be located within the internal bores 136, 138 of the heel member 128 and the internal bore 144 of the top plug insert 130 of the compressible member 110. In one embodiment, the internal bore 144 of the top plug insert 130 is located within the compressible member 110 and between the sidewalls 132, 134, the front wall 133, and the rear wall 135 of the heel member 128 of the compressible member 110. In one embodiment, the internal bore 144 of the top plug insert 130 is located within the compressible member 110 and between the sidewalls 132, 134, the front wall 133, and the rear wall 135 of the heel member 128 of the compressible member 110 and oriented substantially horizontally therewithin. While the shape of the valve housing 152 of the valve system 126 is shown as generally cylindrical, any configuration and shape may be contemplated. The valve housing 152 may comprise the fitting 162 located at a first end and the exhaust port 160 located at a second end opposite the first end. The internal bores 136, 138 of the heel member 128 and the internal bore 144 of the top plug insert 130 and the valve housing 152 are typically designed with generally the same shape and dimensions such that a tight fit of the valve housing 152 within the internal bore(s) exists.


The fitting 162 may be coupled to the air return 154 at the first end, which in turn may be connected to the user's prosthetic socket that contains the vacuum attachment apparatus (not shown). The first valve 156 may be coupled to the second end of the fitting 162 by any suitable manner. In one embodiment, the fitting 162 has a ⅛ inch internal diameter tube fitting at the first end, and 10-32 UNF threaded connection with an O-ring gasket that seals a mating face 166 of the fitting 162 to an internal wall 168 of the valve housing 152 when fully tightened down and installed within the inner bore 130. An example of the fitting 162 is produced by Pneumadyne® and is part number EB-30-250.


The exhaust port 160 may be coupled to the second end of the valve housing 152. The exhaust port 160 may be coupled to the valve housing 152 in any suitable manner. In one embodiment, the exhaust port 160 may comprise a filtered exhaust port through which the air exiting travels to the atmosphere at a first end of the exhaust port. Some examples of the exhaust port are McMaster-Carr® part number 9833K18 or alternatively Industrial Specialties Mfg. part number BV-1032M-40-B. In one embodiment, the McMaster-Carr® part is sealed using Teflon® tape on the threads of the fitting. In one embodiment, the Industrial Specialties Mfg. part has an O-ring gasket that seals the mating face to the housing when fully tightened within the valve housing 152.


In various embodiments, the second valve 158 may be located adjacent an internal end of the exhaust port 160. The first and second valves 156, 158 may comprise one-way duckbill valves. The one-way duckbill valve design has a very low cracking pressure (to allow air in the designed direction of travel) and does not allow air to travel in the reverse direction. In one embodiment, the one-way duckbill valve is produced by Minivalve International, part number DU027.002-154. The second valve 158 allows air to exit the valve housing 152 into the atmosphere, while the first valve 156 permits air to enter valve housing 152, as will be discussed in detail below. The area between the first valve 156 and second valve 158 may comprise an open-air chamber 164 that allows air to flow between the two valves. This open air chamber 164 is connected to air passageway 148 by the valve housing passageway 165 and provides free air flow to the chamber 124 within the compressible member 110.


In operation, when a downward force is applied to the prosthetic foot 102, the compressible member 110 and the chamber 124 located therein are compressed when they come into contact with the resilient bottom member 104. The compression of the chamber 124 within the compressible member 110 forces air out of the chamber 124 up through air passageway 148 and into valve housing 152. The pressurized air exits the valve housing 152 through the second valve 158 and the exhaust port 160. When the downward force on the prosthetic foot 102 is reduced or eliminated, the compressible member 110 returns the chamber 124 back to a maximum volume state due to the elastic properties of compressible member 110. The elastic properties and geometry of compressible member 110 allow chamber 124 to expand back to the initial volume when the downward force is eliminated or reduced to the point that the compressible member 110 is no long in contact with the resilient bottom member 104. The second valve 158 then closes and prevents a backflow of air into the valve housing 152 through the exhaust port 160. This causes a negative pressure in valve housing 152. The negative pressure draws air into the valve housing 152 through first valve 156 by way of the fitting 162 and the air return 154. The air return 154 is connected to a prosthetic socket that is designed for an elevated vacuum suspension and the like. The elevated vacuum suspension socket is a commercially available prosthetic socket that uses an elevated vacuum level inside the socket to secure the socket to the amputee's residual limb.


In various embodiments, the compressible member 110 comprises an elastomeric bumper member having a tapered surface configured to contact the resilient bottom member 104 and attached to an underside of a rear top end of the upper member 106. The compressible member 110 can be vertically oriented with respect to the prosthetic foot 102. The compressible member 110 can act as a heel shock for absorbing force on the downward strike during the user's stride and returns energy during the rest of the gait cycle.


In various embodiments, the compressible member 110 can be made from an elastomeric material. In one embodiment, the elastomeric material may be constructed of natural, synthetic or a hybrid mixture of both natural and synthetic rubber. The elastomeric material has about 80% or greater energy return. In another embodiment, the elastomeric material has about 90% or greater energy return. The compressible member 110 can be designed to behave similar to a non-linear spring, thereby allowing larger deflection of the posterior toe during the heel strike. The progressive “spring rate” may lead to a soft initial heel strike but quickly and gently arrests deflection as the compressible member 110 compresses. One benefit of the compressible member 110 is being relatively lightweight in comparison to a prosthetic foot with coiled springs.


As seen in FIG. 4, the compressible member 110 can be located posterior to a vertical axis of the connection point of the mounting portion 120. This enhances the aforementioned and desirable trait of tibial progression. The compressible member 110 can be attached to the underside of the resilient top member 106 in various manners. For example, the compressible member 110 can be fixedly attached using adhesive or fasteners, such as screws. In another example, the compressible member 110 may be detachable using fasteners for replacement purposes. Moreover, in other embodiments, the compressible member 110 can be attached to various locations on the underside of the resilient top member 106 or topside of the resilient bottom member 104. In various embodiments, the prosthetic foot 100 in a static mode has a gap between the compressible member 110 and the resilient bottom member 104. For example, a gap of about 1/10 inch may be present between the compressible member 110 and the resilient bottom member 104. In other various methods, the compressible member 110 can be in contact with both the resilient top member 106 and the resilient bottom member 104 when the prosthetic foot 100 is in a static position. The lack of a gap results in the compressible member 110 being continuously compressed during the gait cycle, though the compressible member 110 is a compression member and not a tension member since the compressible member 110 is only attached to either the top member 106 or the resilient bottom member 104. It is important to the design of the compressible member such that it is only attached to one or the other of the resilient top member 106 and the resilient bottom member 104 and not to both. Connecting the compressible member 110 to both the resilient top and bottom members 106, 104 creates almost a triangle structure, which is very stiff.


The compressible member 110 can be in many shapes. In various embodiments, the detached portion of the compressible member 110 may have a conical, rectangular, or pyramid shape. The tapered surface of the compressible member 110 can terminate in an apex or hemispherical shape, and the apex can be configured to contact the resilient bottom member 104 in response to deflection of the prosthetic foot 100. Moreover, in various embodiments, the compressible member 110 can terminate in multiple points. The tapered compressible member 110 facilitates a damping of vibration and sound generated during heel strike or release. Furthermore, in various embodiments the extruding portion of the compressible member 110 may be any shape that is non-flat surface. Further, a non-flat surface enhances lateral flexibility if the heel strike is not vertical.


The prosthetic foot 100 can be adjusted to accommodate a user in part by adjusting characteristics of the compressible member 110. For example, in various embodiments, the durometer of the compressible member 110 can be increased for users with more heel strike force, which may be caused by additional weight or dynamic activity. A heavier user may be better-suited using a compressible member 110 with a large cross-sectional area compared to a lighter user using a compressible member 110 with a small cross-sectional area. The adjustable durometer of the elastomeric material used for the compressible member 110 allows the adjustment of spring rate of the elastomeric heel based on user needs such as activity level, compliance level, weight changes, and the like. Increased durometer can also adjust the ability of chamber 124 to return to the initial volume after being compressed.


In various embodiments, and referring now to FIGS. 15-21, an additional embodiment of a compressible member 172 may comprise a heel member 174 and a side plug insert 176. The valve system 126 described above may be implemented with the compressible member 172. The heel member 174 comprises a sidewall 178 with internal bore 180, a cavity 182 that receives the side plug insert 176 and a pair of internal voids 184, 186.


The side plug insert 176 may comprise an internal bore 188 and a pair of voids 190, 192. When the side plug insert 176 is placed within the cavity 182 the internal bore 180 of heel member 174 aligns with the internal bore 188 of the side plug insert 176 to receive the valve system 126 (not shown). Additionally, the pair of internal voids 190, 192 of the side plug insert and the pair of internal voids 184, 186 of the heel member 174 combine to form an air passageway 194 and a chamber 196.


The side plug insert 176 is both bonded in place as discussed above, and mechanically locked by the valve system 126 which protrudes through the internal bore 180 of heel member 174 and the internal bore 188 of the side plug insert 176. It should be understood that orientation of the side plug insert and heel member may be reversed, for example, the side plug insert can be placed in a cavity on either side of the heel member.


Referring now to FIGS. 22-24, the vacuum system 100 for a prosthetic foot may comprise a compressible member 198, a chamber 200 located within the compressible member 198, and the valve system 126 that connects to the prosthetic socket of the user (not shown).


In various embodiments the chamber 200 may be located within the compressible member 198 and is connected to the valve system 126 by an air passageway 202. The valve system 126 described above may be implemented with a bore 204 located within the compressible member 198. In one embodiment, the chamber 200 may be formed by molding in a void in each left and right halves of compressible member 198 and consequently bonding the left and right halves of compressible member 198 into a single piece. In one embodiment, the chamber 200 may be formed by molding in a void and sealing the void at one end with a separate piece made of the same material as the compressible member 198 and bonding it into place. In various embodiments, chamber 200 may be formed by 3D printing the material or by a material removal process, such as, cutting or machining and drilling the material. In one embodiment, chamber 200 may comprise a generally rectangular in shape when viewed from the top. When viewed from the rear and side, as shown in FIGS. 23 and 24, the chamber 200 is roughly elliptical in shape, which allows the chamber 200 to fully collapse when loaded. In another embodiment, chamber 200 is generally rectangular when viewed from the side and from the back. In another embodiment, the chamber 200 may comprise an upside-down T shape when viewed from the side or rear. In one embodiment the volume of chamber 200 is approximately 0.1 to 0.25 cubic inches. It should be understood that any volume contemplated may be used as long as the volume is configured to provide enough back pressure to seal the socket to the residual limb.


The chamber 200 may be connected to valve housing 152 by way of the air passageway 202. In various embodiments, the air passageway 202 can be a void in the heel mold or a separate tube located inside compressible member 198 or located between the left and right halves of the compressible member 198. The separate tube comprising air passageway 202 may be small diameter stainless steel tubing, or small diameter carbon fiber tubing, small diameter flexible plastic tubing, and the like. Alternatively, air passageway 202 may connect chamber 200 to valve housing 152 in a way external to compressible member 198.


It should be understood that the compressible members 172, 198 are shaped, located, oriented, constructed, and attached to the prosthetic foot similarly to the compressible member 110 discussed above. It should be understood that the compressible members 172, 198 also function similarly to the compressible member 110 discussed above.


The technology has been described with reference to specific exemplary embodiments. Various modifications and changes, however, may be made without departing from the scope of the present technology. The description and figures are to be regarded in an illustrative manner, rather than a restrictive one and all such modifications are intended to be included within the scope of the present technology. Accordingly, the scope of the technology should be determined by the generic embodiments described and their legal equivalents rather than by merely the specific examples described above. For example, the steps recited in any method or process embodiment may be executed in any order, unless otherwise expressly specified, and are not limited to the explicit order presented in the specific examples. Additionally, the components and/or elements recited in any apparatus embodiment may be assembled or otherwise operationally configured in a variety of permutations to produce substantially the same result as the present technology and are accordingly not limited to the specific configuration recited in the specific examples.


Benefits, other advantages and solutions to problems have been described above with regard to particular embodiments; however, any benefit, advantage, solution to problems or any element that may cause any particular benefit, advantage or solution to occur or to become more pronounced are not to be construed as critical, required or essential features or components.


As used herein, the terms “comprises”, “comprising”, or any variation thereof, are intended to reference a non-exclusive inclusion, such that a process, method, article, composition or apparatus that comprises a list of elements does not include only those elements recited, but may also include other elements not expressly listed or inherent to such process, method, article, composition or apparatus. Other combinations and/or modifications of the above-described structures, arrangements, applications, proportions, elements, materials or components used in the practice of the present technology, in addition to those not specifically recited, may be varied or otherwise particularly adapted to specific environments, manufacturing specifications, design parameters or other operating requirements without departing from the general principles of the same.


The present technology has been described above with reference to a preferred embodiment. However, changes and modifications may be made to the preferred embodiment without departing from the scope of the present technology. These and other changes or modifications are intended to be included within the scope of the present technology, as expressed in the following claims.

Claims
  • 1. A prosthetic foot for use with a prosthetic socket containing a vacuum attachment apparatus and configured to attach to a residual limb, the prosthetic foot comprising: a resilient bottom member comprising a front end and a rear end;a resilient top member comprising a front end and a rear end, wherein the front end of the resilient top member is connected to the front end of the resilient bottom member, and wherein the resilient top member is positioned over the resilient bottom member;a vacuum system coupled to an underside of the top member, the vacuum system comprising: a compressible member comprising: a heel member comprising a pair of sidewalls, a front wall, a rear wall, and a cavity; anda top plug insert that is received between the sidewalls and within the cavity to form a chamber;a valve system received within the compressible member;a passageway connecting the valve system and the chamber; andan air return coupled to the valve system and the vacuum attachment apparatus.
  • 2. The prosthetic foot of claim 1, wherein an upper internal surface of the cavity and a lower surface of the top plug insert form the chamber.
  • 3. The prosthetic foot of claim 1, wherein each of the pair of sidewalls of the heel member comprises an internal bore.
  • 4. The prosthetic foot of claim 3, wherein the top plug insert comprises an internal bore.
  • 5. The prosthetic foot of claim 4, wherein when the top plug insert is received within the heel member, the internal bores of the heel member align with the internal bore of the top plug insert to receive the valve system and lock the top plug insert within the heel member.
  • 6. The prosthetic foot of claim 1, wherein the valve system comprised: a housing comprising a first end and a second end;a first valve located within the housing at the first end;a second valve located within the housing at the second end;an air chamber located within the housing between the first valve and the second valve;an exhaust port coupled to the second valve; andthe air return coupled to the first valve.
  • 7. The prosthetic foot of claim 6, wherein the passageway is in air communication with the cavity in the compressible member and the air chamber in the valve system housing.
  • 8. The prosthetic foot of claim 1, wherein the top plug insert is coupled within the heel member.
  • 9. The prosthetic foot of claim 8, wherein the top plug insert is bonded within the heel member.
  • 10. The prosthetic foot of claim 9, wherein the top plug insert is bonded within the heel member using an adhesive.
  • 11. The prosthetic foot of claim 1, wherein the chamber is compressed when the compressible member contacts the resilient bottom member in response to an applied downward force on the resilient top member.
  • 12. The prosthetic foot of claim 11, wherein the compression of the chamber within the compressible member forces air out of the chamber through the passageway and out of the valve system.
  • 13. The prosthetic foot of claim 11, wherein upon removal of the downward force, the chamber expands causing a negative pressure within the valve assembly and activates the vacuum attachment apparatus through the air return.
  • 14. The prosthetic foot of claim 13, wherein the chamber is configured to expand due to elastomeric properties of the compressible member.
  • 15. A prosthetic foot for use with a prosthetic socket containing a vacuum attachment apparatus and configured to attach to a residual limb, the prosthetic foot comprising: a resilient bottom member comprising a front end and a rear end;a resilient top member comprising a front end and a rear end, wherein the front end of the resilient top member is connected to the front end of the resilient bottom member; anda vacuum system coupled to an underside of the rear end of the top member the vacuum system comprising: a compressible member, comprising: a heel member comprising a pair of sidewalls, a front wall, a rear wall, and a cavity; anda top plug insert that is received between the sidewalls and within the cavity to form a chamber;a valve system received within the compressible member;a single passageway connecting the valve system and the chamber; andan air return coupled to the valve system and the vacuum attachment apparatus.
  • 16. The prosthetic foot of claim 15, wherein an upper internal surface of the cavity and a lower surface of the top plug insert form the chamber.
  • 17. The prosthetic foot of claim 16, wherein the chamber is compressed when the compressible member contacts the resilient bottom member in response to an applied downward force on the resilient top member.
  • 18. The prosthetic foot of claim 16, wherein upon removal of the downward force, the chamber expands causing a negative pressure within the valve assembly and activates the vacuum attachment apparatus through the air return.
  • 19. A vacuum system for use with a prosthetic socket containing a vacuum attachment apparatus and a prosthetic foot comprising a resilient bottom member and a resilient top member, wherein an underside of a front end of the resilient top member is coupled to a front end of the resilient bottom member, the vacuum system comprising: a compressible member configured to be coupled to the underside of the rear end of the resilient top member, the compressible member comprising: a heel member comprising a pair of sidewalls, a front wall, a rear wall, and a cavity; anda top plug insert that is received between the sidewalls, the front wall, the rear wall and within the cavity to form a chamber;a valve system received within the compressible member;a single passageway connecting the valve system and the chamber; andan air return configured to couple to the valve system and the vacuum attachment apparatus,wherein the chamber is configured to be compressed when the compressible member contacts the resilient bottom member in response to an applied downward force on the resilient top member, and wherein the chamber is configured so as to expand upon removal of the downward force which in turn would cause a negative pressure within the valve assembly and activation of the vacuum attachment apparatus through the air return.
CROSS-REFERENCES TO RELATED APPLICATIONS

The present application claims the benefit of U.S. Provisional Application Ser. No. 62/550,107, filed Aug. 25, 2017 and U.S. Provisional Application Ser. No. 62/589,025, filed Nov. 21, 2017; and is a continuation in part of U.S. patent application Ser. No. 14/976,129, filed Dec. 21, 2015, which is a continuation of U.S. patent application Ser. No. 14/731,818, filed Jun. 5, 2015, which is a continuation of U.S. patent application Ser. No. 13/568,535, filed on Aug. 7, 2012; and this application is a continuation in part of U.S. patent application Ser. No. 14/976,129, filed Dec. 21, 2015, which is a continuation of U.S. patent application Ser. No. 14/731,818, filed Jun. 5, 2015, which is a continuation of U.S. patent application Ser. No. 13/568,535, filed on Aug. 7, 2012, which is a continuation-in-part of International Application No. PCT/US11/33319, filed on Apr. 20, 2011, which is a continuation-in-part of U.S. patent application Ser. No. 12/799,215, filed on Apr. 20, 2010, which is a continuation-in-part of U.S. patent application Ser. No. 11/901,845, filed on Sep. 19, 2007, now U.S. Pat. No. 8,048,173; and this application is a continuation in part of U.S. patent application Ser. No. 14/731,818, filed Jun. 5, 2015, which is a continuation of U.S. patent application Ser. No. 13/568,535, filed on Aug. 7, 2012, which is a continuation-in-part of International Application No. PCT/US11/33319, filed on Apr. 20, 2011, which is a continuation-in-part of U.S. patent application Ser. No. 12/799,215, filed on Apr. 20, 2010, which is a continuation-in-part of U.S. patent application Ser. No. 11/901,845, filed on Sep. 19, 2007, now U.S. Pat. No. 8,048,173; and this application is a continuation-in-part of U.S. patent application Ser. No. 14/731,771, filed Jun. 5, 2015, which is a continuation of U.S. patent application Ser. No. 13/642,501, filed on Nov. 27, 2012, now U.S. Pat. No. 9,078,773, which is a 371 national phase application of International Application No. PCT/US11/33319, filed on Apr. 20, 2011, which is a continuation-in-part of U.S. patent application Ser. No. 12/799,215, filed on Apr. 20, 2010, which is a continuation-in-part of U.S. patent application Ser. No. 11/901,845, filed on Sep. 19, 2007, now U.S. Pat. No. 8,048,173 and incorporates the disclosure of all such applications by reference, and this application incorporates the disclosure of all such applications by reference.

US Referenced Citations (737)
Number Name Date Kind
3131307 Bock Apr 1964 A
3331546 Brunelle Jul 1967 A
4186449 Horvath Feb 1980 A
4310932 Nader et al. Jan 1982 A
4473421 Gustafsson Sep 1984 A
4497315 Fettweis et al. Feb 1985 A
4506395 Haupt Mar 1985 A
4515153 Calabrese May 1985 A
4547913 Phillips Oct 1985 A
4634446 Kristinsson Jan 1987 A
4677969 Calabrese Jul 1987 A
4815471 Stobie Mar 1989 A
4844094 Grim Jul 1989 A
4852557 Grim Aug 1989 A
4854428 Horvath Aug 1989 A
4856501 Castillo et al. Aug 1989 A
4869267 Grim et al. Sep 1989 A
4886052 Calabrese Dec 1989 A
4893648 Horvath Jan 1990 A
4913755 Grim Apr 1990 A
4923474 Klasson et al. May 1990 A
4928678 Grim May 1990 A
4940044 Castillo Jul 1990 A
4949335 Moore Aug 1990 A
4953543 Grim et al. Sep 1990 A
4958705 Horvath Sep 1990 A
4959073 Merlette Sep 1990 A
4977891 Grim Dec 1990 A
D314623 Calabrese et al. Feb 1991 S
4993409 Grim Feb 1991 A
4996979 Grim et al. Mar 1991 A
5007937 Fishman et al. Apr 1991 A
5027801 Grim Jul 1991 A
5054475 Calabrese et al. Oct 1991 A
5058576 Grim et al. Oct 1991 A
5078128 Grim et al. Jan 1992 A
5088478 Grim Feb 1992 A
5092902 Adams et al. Mar 1992 A
5107824 Rogers et al. Apr 1992 A
5108456 Coonan, III Apr 1992 A
5127420 Horvath Jul 1992 A
5135469 Castillo Aug 1992 A
5139525 Kristinsson Aug 1992 A
5156588 Marcune et al. Oct 1992 A
5156631 Merlette Oct 1992 A
5201903 Corbett, III et al. Apr 1993 A
5277698 Taylor Jan 1994 A
5288287 Castillo et al. Feb 1994 A
5302169 Taylor Apr 1994 A
5302170 Tweardy Apr 1994 A
RE34661 Grim Jul 1994 E
5333604 Green et al. Aug 1994 A
5334135 Grim et al. Aug 1994 A
5348530 Grim et al. Sep 1994 A
5353525 Grim Oct 1994 A
5376131 Lenze et al. Dec 1994 A
5376132 Caspers Dec 1994 A
5378223 Grim et al. Jan 1995 A
RE34883 Grim Mar 1995 E
D357070 Castillo Apr 1995 S
5405409 Knoth Apr 1995 A
5437612 Moore et al. Aug 1995 A
5443521 Knoth et al. Aug 1995 A
5445602 Grim et al. Aug 1995 A
5458656 Phillips Oct 1995 A
5462551 Bailey et al. Oct 1995 A
5464385 Grim Nov 1995 A
5468139 Stender Nov 1995 A
RE35113 Grim Dec 1995 E
5472412 Knoth Dec 1995 A
5490832 Brown Feb 1996 A
5515848 Corbett, III et al. May 1996 A
5529575 Klotz Jun 1996 A
5534034 Caspers Jul 1996 A
5545233 Fitzlaff Aug 1996 A
5549709 Caspers Aug 1996 A
5554105 Taylor Sep 1996 A
5562605 Taylor Oct 1996 A
5571205 James Nov 1996 A
5571208 Caspers Nov 1996 A
5593456 Merlette Jan 1997 A
5603122 Kania Feb 1997 A
5628721 Arnold et al. May 1997 A
5630839 Corbett, III et al. May 1997 A
5632723 Grim May 1997 A
5658353 Layton Aug 1997 A
5695452 Grim et al. Dec 1997 A
5702489 Slemker Dec 1997 A
5713837 Grim et al. Feb 1998 A
5716335 Iglesias et al. Feb 1998 A
5728170 Becker et al. Mar 1998 A
5778565 Holt et al. Jul 1998 A
5797713 Tweardy et al. Aug 1998 A
5797864 Taylor Aug 1998 A
5800500 Spelman et al. Sep 1998 A
5823981 Grim et al. Oct 1998 A
5851504 Barker et al. Dec 1998 A
5885509 Kristinsson Mar 1999 A
5888212 Petrofsky et al. Mar 1999 A
5888217 Slemker Mar 1999 A
5888238 Phillips et al. Mar 1999 A
5897594 Martin et al. Apr 1999 A
5904721 Henry et al. May 1999 A
5904722 Caspers May 1999 A
5931872 Lohmann Aug 1999 A
5951504 Iglesias et al. Sep 1999 A
6002014 Haruta et al. Dec 1999 A
6003176 Wasley et al. Dec 1999 A
6007505 Grim et al. Dec 1999 A
6013094 De Cubber et al. Jan 2000 A
6024712 Iglesias et al. Feb 2000 A
6063125 Arbogast et al. May 2000 A
6071255 Calabrese Jun 2000 A
6099572 Mosler et al. Aug 2000 A
6136039 Kristinsson et al. Oct 2000 A
6139513 Grim et al. Oct 2000 A
D433756 Castillo Nov 2000 S
6145796 McCraney Nov 2000 A
6149690 Belzidsky Nov 2000 A
6186966 Grim et al. Feb 2001 B1
6231616 Helmy May 2001 B1
6231617 Fay May 2001 B1
6254560 Tweardy et al. Jul 2001 B1
6287345 Slemker et al. Sep 2001 B1
D452325 Henderson Dec 2001 S
6326412 Weber et al. Dec 2001 B1
6334876 Perkins Jan 2002 B1
6346559 Thiele et al. Feb 2002 B1
6361568 Hoerner Mar 2002 B1
6383149 DeMayo May 2002 B1
6415796 Conrad et al. Jul 2002 B1
6416518 DeMayo Jul 2002 B1
6416703 Kristinsson et al. Jul 2002 B1
6453905 Conrad et al. Sep 2002 B1
6461317 Grim et al. Oct 2002 B1
6482167 Grim et al. Nov 2002 B2
6502574 Stevens et al. Jan 2003 B2
6508842 Caspers Jan 2003 B1
6513530 Knudson et al. Feb 2003 B2
6513531 Knudson et al. Feb 2003 B2
6516806 Knudson et al. Feb 2003 B2
6523541 Knudson et al. Feb 2003 B2
6523542 Knudson et al. Feb 2003 B2
D473654 Iglesias et al. Apr 2003 S
6585774 Dean, Jr. et al. Jul 2003 B2
6592539 Einarsson et al. Jul 2003 B1
6596029 Gramnas Jul 2003 B1
6601584 Knudson et al. Aug 2003 B2
6605118 Capper et al. Aug 2003 B2
6645253 Caspers Nov 2003 B2
6660204 Clover, Jr. et al. Dec 2003 B1
6663581 Calabrese Dec 2003 B1
6666894 Perkins et al. Dec 2003 B2
6685655 DeMayo Feb 2004 B2
6746414 Devreese Jun 2004 B1
6761742 Caspers Jul 2004 B2
6767370 Mosler et al. Jul 2004 B1
D496106 Iglesias et al. Sep 2004 S
D496464 Iglesias et al. Sep 2004 S
6792699 Long et al. Sep 2004 B2
6797008 Arbogast et al. Sep 2004 B1
6820621 DeMayo Nov 2004 B2
6824522 Henderson et al. Nov 2004 B2
D503480 Ingimundarson et al. Mar 2005 S
6863695 Doddroe et al. Mar 2005 B2
D503802 Bjarnason Apr 2005 S
6875187 Castillo Apr 2005 B2
6896678 Tweardy May 2005 B2
6899737 Phillips et al. May 2005 B1
6923834 Karason Aug 2005 B2
6926742 Caspers et al. Aug 2005 B2
6929613 Henderson et al. Aug 2005 B2
6936073 Karason Aug 2005 B2
6953443 Hay Oct 2005 B2
6964688 Kania Nov 2005 B1
6969364 Sterling Nov 2005 B2
6974484 Caspers Dec 2005 B2
6979355 Slemker Dec 2005 B1
7001563 Janusson et al. Feb 2006 B2
7004917 Henderson et al. Feb 2006 B2
7018351 Iglesias et al. Mar 2006 B1
7037283 Karason et al. May 2006 B2
7037287 Cormier et al. May 2006 B2
7044925 Castillo et al. May 2006 B2
D523149 Bjarnason Jun 2006 S
7063727 Phillips et al. Jun 2006 B2
7077818 Ingimundarson et al. Jul 2006 B2
7094058 Einarsson Aug 2006 B2
7094212 Karason et al. Aug 2006 B2
D527825 Ingimundarson et al. Sep 2006 S
D529180 Ingimundarson et al. Sep 2006 S
7100225 Bailey et al. Sep 2006 B1
7100613 Conrad et al. Sep 2006 B2
7105122 Karason Sep 2006 B2
7107180 Karason Sep 2006 B2
D533280 Wyatt et al. Dec 2006 S
7144429 Carstens Dec 2006 B2
7150762 Caspers Dec 2006 B2
7169188 Carstens Jan 2007 B2
7169189 Bjarnason et al. Jan 2007 B2
7169190 Phillips et al. Jan 2007 B2
7172567 Lidolt et al. Feb 2007 B2
7198071 Bisbee, III et al. Apr 2007 B2
7198610 Ingimundarson et al. Apr 2007 B2
7201728 Sterling Apr 2007 B2
7217060 Ingimarsson May 2007 B2
7223293 Kristensen May 2007 B2
7235108 Carstens Jun 2007 B2
7237553 Knudson et al. Jul 2007 B2
7240876 Doubleday et al. Jul 2007 B2
7255109 Knudson et al. Aug 2007 B2
7255110 Knudson et al. Aug 2007 B2
7288076 Grim et al. Oct 2007 B2
7291182 Kania Nov 2007 B1
RE39961 Petrofsky et al. Dec 2007 E
D557828 Willman Dec 2007 S
7303538 Grim et al. Dec 2007 B2
7335233 Hsu et al. Feb 2008 B2
7341123 Brendel et al. Mar 2008 B2
D567072 Ingimundarson et al. Apr 2008 S
7371262 Lecomte et al. May 2008 B2
RE40363 Grim et al. Jun 2008 E
7413555 Wagner et al. Aug 2008 B2
7415741 Wasley et al. Aug 2008 B1
D576781 Chang et al. Sep 2008 S
D577828 Ingimundarson et al. Sep 2008 S
7426930 Bailey et al. Sep 2008 B1
7427297 Patterson et al. Sep 2008 B2
7427298 Swanson, Sr. Sep 2008 B1
7431708 Sreeramagiri Oct 2008 B2
7438843 Asgeirsson Oct 2008 B2
7449005 Pickering et al. Nov 2008 B2
7465281 Grim et al. Dec 2008 B2
7465283 Grim et al. Dec 2008 B2
7468079 Collier Dec 2008 B2
7479162 Kurth Jan 2009 B2
D588753 Ingimundarson et al. Mar 2009 S
7513880 Ingimundarson et al. Apr 2009 B2
D592756 Chang et al. May 2009 S
7531006 Clausen et al. May 2009 B2
7544214 Gramnas Jun 2009 B2
7549970 Tweardy Jun 2009 B2
D596301 Campos et al. Jul 2009 S
7611476 Taranow Nov 2009 B2
7631657 Alley et al. Dec 2009 B2
7632315 Egilsson Dec 2009 B2
7662191 Asgeirsson Feb 2010 B2
D611322 Robertson Mar 2010 S
7670385 Klein Mar 2010 B2
7691154 Asgeirsson et al. Apr 2010 B2
D616555 Thorgilsdottir et al. May 2010 S
D616556 Hu May 2010 S
D616996 Thorgilsdottir et al. Jun 2010 S
D616997 Thorgilsdottir et al. Jun 2010 S
D618359 Einarsson Jun 2010 S
7744653 Rush et al. Jun 2010 B2
7745682 Sigurjonsson et al. Jun 2010 B2
7762970 Henderson et al. Jul 2010 B2
7762973 Einarsson et al. Jul 2010 B2
7771487 Mantelmacher Aug 2010 B2
7780741 Janusson et al. Aug 2010 B2
7803301 Becker et al. Sep 2010 B2
D627079 Robertson Nov 2010 S
7833181 Cormier et al. Nov 2010 B2
7842099 Mantelmacher Nov 2010 B2
D628696 Robertson Dec 2010 S
D629115 Robertson Dec 2010 S
7867182 Iglesias et al. Jan 2011 B2
7867286 Einarsson Jan 2011 B2
7879110 Phillips Feb 2011 B2
7883547 Mantelmacher Feb 2011 B2
7891258 Clausen et al. Feb 2011 B2
7892195 Grim et al. Feb 2011 B2
D634438 Hu Mar 2011 S
D634852 Hu Mar 2011 S
7896826 Hu et al. Mar 2011 B2
7896827 Ingimundarson et al. Mar 2011 B2
7914475 Wyatt et al. Mar 2011 B2
7914586 Haines Mar 2011 B2
7922775 Caspers Apr 2011 B2
7927378 Scussel Apr 2011 B2
D637942 Lee et al. May 2011 S
7935153 Auberger May 2011 B2
D640380 Tweardy et al. Jun 2011 S
D640381 Tweardy et al. Jun 2011 S
7963998 Boiten Jun 2011 B2
D641483 Robertson et al. Jul 2011 S
7985193 Thorsteinsson et al. Jul 2011 B2
D643537 Lee Aug 2011 S
D646394 Tweardy et al. Oct 2011 S
D647623 Thorgilsdottir et al. Oct 2011 S
D647624 Thorgilsdottir et al. Oct 2011 S
8038636 Thorgilsdottir et al. Oct 2011 B2
8048082 Demayo Nov 2011 B1
8052760 Egilsson et al. Nov 2011 B2
8080065 Scussel et al. Dec 2011 B2
8083807 Auberger et al. Dec 2011 B2
D652937 Robertson et al. Jan 2012 S
8092406 Gorsen Jan 2012 B2
8093445 Sigurjonsson et al. Jan 2012 B2
8097042 Slemker et al. Jan 2012 B2
8097043 Egilsson Jan 2012 B2
8114041 Wyatt et al. Feb 2012 B2
8117720 Kimes Feb 2012 B2
8132278 Bailey Mar 2012 B1
8177855 Asgeirsson et al. May 2012 B2
D661807 Sigurdsson Jun 2012 S
8202325 Albrecht-Laatsch et al. Jun 2012 B2
8211187 Slemker et al. Jul 2012 B2
8216166 Einarsson et al. Jul 2012 B2
D665505 Lee et al. Aug 2012 S
D665539 Manalo et al. Aug 2012 S
8247635 Sigurjonsson et al. Aug 2012 B2
8251928 Pusch Aug 2012 B2
8257293 Ingimundarson et al. Sep 2012 B2
8257446 Puchhammer Sep 2012 B2
8267879 Ingimundarson et al. Sep 2012 B2
8273042 Lidolt et al. Sep 2012 B2
8277404 Einarsson Oct 2012 B2
8277515 Martin Oct 2012 B2
8282588 Ingimundarson et al. Oct 2012 B2
D671275 Manalo et al. Nov 2012 S
8303670 Martin et al. Nov 2012 B2
8308815 Mccarthy Nov 2012 B2
8308816 Slemker et al. Nov 2012 B2
8317875 Jonsson et al. Nov 2012 B2
8317876 Mosler Nov 2012 B2
D672878 Einarsson Dec 2012 S
8328746 Ingimundarson et al. Dec 2012 B2
8353807 Kruijsen et al. Jan 2013 B2
8356604 Tweardy et al. Jan 2013 B2
8382852 Laghi Feb 2013 B2
8409298 Perkins et al. Apr 2013 B2
8409299 Kurth Apr 2013 B2
8410331 Janusson et al. Apr 2013 B2
8425441 Ingimundarson Apr 2013 B2
D683465 Forbes et al. May 2013 S
8444702 Slemker et al. May 2013 B2
8454546 Campos et al. Jun 2013 B2
8459264 Tweardy Jun 2013 B2
8475537 King Jul 2013 B2
8476172 Christof Jul 2013 B2
8486156 Jonsson Jul 2013 B2
8491515 Schneider Jul 2013 B2
8496715 Street et al. Jul 2013 B2
8505864 Taylor et al. Aug 2013 B1
8517964 Sreeramagiri et al. Aug 2013 B2
D690473 Manalo et al. Sep 2013 S
8523951 Kania Sep 2013 B2
8530424 Lundborg Sep 2013 B2
8535390 Lecomte et al. Sep 2013 B1
8540781 Nissels et al. Sep 2013 B2
8555715 Langlois et al. Oct 2013 B2
8568489 Finlinson et al. Oct 2013 B2
D693930 Manalo Nov 2013 S
8603190 Olafsson et al. Dec 2013 B2
8644921 Wilson Feb 2014 B2
8644939 Wilson et al. Feb 2014 B2
8652217 Haynes et al. Feb 2014 B2
8653937 Haynes et al. Feb 2014 B2
8657986 Gansen et al. Feb 2014 B2
8673199 Ottleben Mar 2014 B2
8679194 Mackenzie Mar 2014 B2
8701674 Tweardy et al. Apr 2014 B2
8721736 Gramnas May 2014 B2
8726823 Kristinsson May 2014 B2
8728171 Kaltenborn et al. May 2014 B2
8733027 Marston et al. May 2014 B1
D707830 Klutts Jun 2014 S
D707831 Klutts Jun 2014 S
8758449 Caspers Jun 2014 B2
8771214 Christenhusz et al. Jul 2014 B2
8771370 Albrecht-Laatsch et al. Jul 2014 B2
8771371 Tompkins Jul 2014 B2
8784501 Gramnas Jul 2014 B2
8789425 Oh et al. Jul 2014 B2
D711510 Halldorsson Aug 2014 S
8795386 Pianykh et al. Aug 2014 B2
8808394 Laghi Aug 2014 B2
8821426 Einarsson et al. Sep 2014 B2
8839797 Demayo Sep 2014 B1
D714939 Gunnsteinsson et al. Oct 2014 S
8858998 Chu et al. Oct 2014 B2
8864692 Ingimundarson et al. Oct 2014 B2
D716955 Forbes et al. Nov 2014 S
D718861 Halldorsson Dec 2014 S
8906113 Mosler et al. Dec 2014 B2
8915874 Schilling Dec 2014 B2
D721810 Sigurdsson et al. Jan 2015 S
8940057 Asgeirsson Jan 2015 B2
8951304 Wu et al. Feb 2015 B2
8961618 Lecomte et al. Feb 2015 B2
8992630 Olafsson et al. Mar 2015 B2
8999428 Anhalt Apr 2015 B2
9011553 Dornieden Apr 2015 B2
9017274 Forbes et al. Apr 2015 B2
9017419 Landry et al. Apr 2015 B1
9017420 Bernhardt Apr 2015 B1
9017421 Lecomte et al. Apr 2015 B2
D729393 Dunn et al. May 2015 S
9039644 Ingimundarson et al. May 2015 B2
9039645 Arnold et al. May 2015 B2
9062785 Mosler et al. Jun 2015 B2
9066820 Mackenzie Jun 2015 B2
D733883 Omarsson et al. Jul 2015 S
9072617 Halldorsson et al. Jul 2015 B2
9089444 Soss et al. Jul 2015 B2
9101323 Einarsson Aug 2015 B2
9168157 Mackenzie Oct 2015 B2
9168158 Clausen et al. Oct 2015 B2
D744111 Dunn et al. Nov 2015 S
9180038 Ingimundarson et al. Nov 2015 B2
9182210 Brookover et al. Nov 2015 B2
9187613 Anhalt Nov 2015 B2
9192488 Bielefeld Nov 2015 B2
D745377 Ressler et al. Dec 2015 S
D745677 Sigurdsson Dec 2015 S
9220622 Ingimundarson et al. Dec 2015 B2
9220624 Jansson et al. Dec 2015 B2
9241812 Martin et al. Jan 2016 B2
9241813 Hillmann Jan 2016 B2
9248032 Gunnarsson et al. Feb 2016 B2
9259332 Danzig et al. Feb 2016 B2
9259333 Mackenzie et al. Feb 2016 B2
9265626 Lecomte et al. Feb 2016 B1
9265628 Tompkins et al. Feb 2016 B2
9265629 Kelley et al. Feb 2016 B2
9265644 Einarsson et al. Feb 2016 B2
9265645 Ingimundarson et al. Feb 2016 B2
9271850 Seyr et al. Mar 2016 B2
9272409 Suhami Mar 2016 B2
9278013 Seyr et al. Mar 2016 B2
D753837 Sigurdsson et al. Apr 2016 S
9345590 Arabian et al. May 2016 B2
9345591 Bisbee, III et al. May 2016 B2
9345605 Dunn et al. May 2016 B2
9351854 Jonsson et al. May 2016 B2
9351864 Romo et al. May 2016 B2
9358138 Kelley et al. Jun 2016 B2
9370440 Ingimundarson et al. Jun 2016 B2
9387096 Sverrisson et al. Jul 2016 B2
9393132 Kranner et al. Jul 2016 B2
9408726 Rowe, Jr. et al. Aug 2016 B2
9427338 Clausen et al. Aug 2016 B2
9439786 Nijman et al. Sep 2016 B2
9468554 Petursson et al. Oct 2016 B2
9474636 Sandahl et al. Oct 2016 B2
9498355 Halldorsson Nov 2016 B2
9510948 Padala Dec 2016 B2
9510967 Lee et al. Dec 2016 B2
D776289 Dunn et al. Jan 2017 S
9532895 Romo Jan 2017 B2
9539135 Romo et al. Jan 2017 B2
9554923 Kettwig et al. Jan 2017 B2
9554935 Ingimundarson et al. Jan 2017 B2
9579220 Jonsson et al. Feb 2017 B2
9579221 Mosler et al. Feb 2017 B2
9589698 Anhalt et al. Mar 2017 B2
9597786 Romo et al. Mar 2017 B2
9603725 Forster et al. Mar 2017 B2
9610177 Duger Apr 2017 B2
9615945 Mosler et al. Apr 2017 B2
9622899 Romo et al. Apr 2017 B2
9636240 Reinelt May 2017 B2
9668903 Hsu et al. Jun 2017 B2
9675472 Mackenzie Jun 2017 B2
9681964 Mackenzie Jun 2017 B2
9687365 Asgeirsson et al. Jun 2017 B2
9707107 Ingimarsson Jul 2017 B2
D795433 Clausen et al. Aug 2017 S
9717606 Gramnaes Aug 2017 B2
9730814 Omarsson et al. Aug 2017 B2
9737420 Van Der Watt et al. Aug 2017 B2
D797292 Clausen et al. Sep 2017 S
9751243 Kroll-Orywahl et al. Sep 2017 B2
9763808 Jonsson Sep 2017 B2
9763810 Hines Sep 2017 B2
9770891 Bjarnason et al. Sep 2017 B2
9775715 Boiten Oct 2017 B2
9782276 Gottlieb et al. Oct 2017 B2
9788977 Halldorsson et al. Oct 2017 B2
9788986 Dunn Oct 2017 B2
9788988 Kompa Oct 2017 B2
9808358 Mosler et al. Nov 2017 B2
9814606 Danzig et al. Nov 2017 B2
9820873 Sandahl Nov 2017 B2
9839536 Bergande Dec 2017 B2
9839548 Ingvarsson et al. Dec 2017 B2
9839549 Walborn et al. Dec 2017 B2
9844448 Karlsson et al. Dec 2017 B2
9844450 Kranner et al. Dec 2017 B2
9872792 Romo et al. Jan 2018 B2
9877851 Egilsson et al. Jan 2018 B2
D810309 Forbes et al. Feb 2018 S
9889034 Gunnsteinsson Feb 2018 B2
9907687 Ingimundarson et al. Mar 2018 B2
9925071 Langlois et al. Mar 2018 B2
9943420 Leiniger et al. Apr 2018 B2
9943431 Chang et al. Apr 2018 B2
9968469 Muller et al. May 2018 B2
9987158 Ingimundarson et al. Jun 2018 B2
9993357 Jonsson Jun 2018 B2
9993381 Blackwell et al. Jun 2018 B2
9999523 Lecomte et al. Jun 2018 B2
10010434 Thorsteinsson et al. Jul 2018 B2
10010435 Schuh et al. Jul 2018 B2
10034782 Sandahl Jul 2018 B2
10039653 Kelley et al. Aug 2018 B2
10051923 Omarsson et al. Aug 2018 B2
10052221 Albertsson et al. Aug 2018 B2
10064749 Hu et al. Sep 2018 B2
10092424 Bache Oct 2018 B2
10117758 Clausen et al. Nov 2018 B2
10123889 Egilsson et al. Nov 2018 B2
10143268 Romo et al. Dec 2018 B2
10143581 Chetlapalli et al. Dec 2018 B2
20020040249 Phillips Apr 2002 A1
20020198245 Haruta et al. Dec 2002 A1
20040024322 Caspers Feb 2004 A1
20040068325 Phillips et al. Apr 2004 A1
20040137178 Janusson et al. Jul 2004 A1
20040163278 Caspers et al. Aug 2004 A1
20040181290 Caspers Sep 2004 A1
20040226115 Gunnsteinsson et al. Nov 2004 A1
20050038525 Doddroe et al. Feb 2005 A1
20050071018 Phillips et al. Mar 2005 A1
20050101693 Arbogast et al. May 2005 A1
20050101896 Calabrese May 2005 A1
20050229317 Heiser et al. Oct 2005 A1
20050234275 Luo et al. Oct 2005 A1
20050234374 Grim et al. Oct 2005 A1
20050234375 Grim et al. Oct 2005 A1
20050267547 Knudson et al. Dec 2005 A1
20050283257 Bisbee, III et al. Dec 2005 A1
20060212128 Nachbar Sep 2006 A1
20070055383 King Mar 2007 A1
20070055384 Perkins et al. Mar 2007 A1
20070080479 Arbogast et al. Apr 2007 A1
20070144538 Tweardy Jun 2007 A1
20070196222 Mosler Aug 2007 A1
20070213829 Le Couedic et al. Sep 2007 A1
20070213839 Nachbar Sep 2007 A1
20080188949 MacKenzie Aug 2008 A1
20090036998 Finlinson Feb 2009 A1
20090076625 Groves et al. Mar 2009 A1
20090182435 Haberman Jul 2009 A1
20090240344 Colvin et al. Sep 2009 A1
20090292370 Pusch et al. Nov 2009 A1
20100030342 Oddsson et al. Feb 2010 A1
20100042227 Schmidt Feb 2010 A1
20100070051 Carstens Mar 2010 A1
20100139530 Ceballos-Godefroy Jun 2010 A1
20110034844 Thorgilsdottir et al. Feb 2011 A1
20110146032 Hu et al. Jun 2011 A1
20110229113 Kurth et al. Sep 2011 A1
20110270413 Haynes Nov 2011 A1
20120000092 Ingvarsson et al. Jan 2012 A1
20120055616 Clausen Mar 2012 A1
20120123559 Mosler et al. May 2012 A1
20120165958 Clausen et al. Jun 2012 A1
20120226364 Kampas et al. Sep 2012 A1
20120226365 Seyr et al. Sep 2012 A1
20120232674 Kampas et al. Sep 2012 A1
20120253475 Kelley et al. Oct 2012 A1
20130006156 Ingimundarson et al. Jan 2013 A1
20130079892 Imhof Mar 2013 A1
20130103125 Radspieler et al. Apr 2013 A1
20130110257 Slemker et al. May 2013 A1
20130144197 Ingimundarson et al. Jun 2013 A1
20130144402 Clausen et al. Jun 2013 A1
20130173020 Slemker et al. Jul 2013 A1
20130190895 Kristinsdottir Jul 2013 A1
20130331951 Doddroe et al. Dec 2013 A1
20140012397 Mosler et al. Jan 2014 A1
20140018938 Bertels et al. Jan 2014 A1
20140046456 Smith Feb 2014 A1
20140063220 Taylor Mar 2014 A1
20140067085 Doddroe et al. Mar 2014 A1
20140116452 Ingimundarson et al. May 2014 A1
20140174849 Gansen Jun 2014 A1
20140188251 Mosler et al. Jul 2014 A1
20140228726 Kruijsen et al. Aug 2014 A1
20140276300 Reinhardt et al. Sep 2014 A1
20140288668 Gottlieb et al. Sep 2014 A1
20150032041 Ingimundarson et al. Jan 2015 A1
20150032225 Oddsson et al. Jan 2015 A1
20150073566 Ragnarsdottir et al. Mar 2015 A1
20150075030 Walborn et al. Mar 2015 A1
20150075537 Demayo Mar 2015 A1
20150079014 Ingvarsson et al. Mar 2015 A1
20150099253 De Roy Apr 2015 A1
20150121657 Ingimundarson et al. May 2015 A1
20150164660 Will et al. Jun 2015 A1
20150164661 Ragnarsdottir et al. Jun 2015 A1
20150197324 Marlin Jul 2015 A1
20150202452 Skiera et al. Jul 2015 A1
20150230943 Marlin et al. Aug 2015 A1
20150230944 Mosler et al. Aug 2015 A1
20150230945 Bache et al. Aug 2015 A1
20150250624 Mosler et al. Sep 2015 A1
20150262319 Tuttle Sep 2015 A1
20150265426 Clausen Sep 2015 A1
20150265429 Jonsson et al. Sep 2015 A1
20150289999 Radspieler Oct 2015 A1
20150297368 Langlois Oct 2015 A1
20150297369 Mosler et al. Oct 2015 A1
20150328020 Clausen et al. Nov 2015 A1
20150366680 Accinni et al. Dec 2015 A1
20150366736 Chetlapalli et al. Dec 2015 A1
20160000584 Brown Jan 2016 A1
20160008147 Marlin Jan 2016 A1
20160008148 Tompkins Jan 2016 A1
20160008157 Brookover et al. Jan 2016 A1
20160009523 Omarsson et al. Jan 2016 A1
20160009526 Mertala et al. Jan 2016 A1
20160022442 Kettwig et al. Jan 2016 A1
20160030203 Pusch et al. Feb 2016 A1
20160067077 Lidolt et al. Mar 2016 A1
20160095734 Sigurdsson et al. Apr 2016 A1
20160120665 Muller May 2016 A1
20160120683 Romo et al. May 2016 A1
20160143764 Klutts May 2016 A1
20160151189 Romo et al. Jun 2016 A1
20160184112 Radspieler Jun 2016 A1
20160184113 Koniuk Jun 2016 A1
20160213823 Walborn et al. Jul 2016 A1
20160220375 Omarsson et al. Aug 2016 A1
20160220409 Romo et al. Aug 2016 A1
20160228114 Demayo Aug 2016 A1
20160242939 Haynes Aug 2016 A1
20160250045 Colvin et al. Sep 2016 A1
20160250061 Ingimundarson et al. Sep 2016 A1
20160262499 Lee et al. Sep 2016 A1
20160278959 Omarsson et al. Sep 2016 A1
20160278963 Webster et al. Sep 2016 A1
20160287237 Demayo et al. Oct 2016 A1
20160287238 Demayo et al. Oct 2016 A1
20160287424 Webster et al. Oct 2016 A1
20160296359 Stefansson et al. Oct 2016 A1
20160296360 Ingimundarson et al. Oct 2016 A1
20160296401 Cole et al. Oct 2016 A1
20160324678 Ingimundarson et al. Nov 2016 A1
20160346100 Sverrisson et al. Dec 2016 A1
20160346112 Ingimundarson et al. Dec 2016 A1
20160346150 Blackwell et al. Dec 2016 A1
20170007435 Klutts Jan 2017 A1
20170020694 Tompkins Jan 2017 A1
20170027716 Friesen et al. Feb 2017 A1
20170027719 Bache et al. Feb 2017 A1
20170027731 Jonsson et al. Feb 2017 A1
20170030694 Mykkanen Feb 2017 A1
20170035583 Monicke et al. Feb 2017 A1
20170035585 Lundborg Feb 2017 A1
20170035586 Egilsson et al. Feb 2017 A1
20170042703 Pusch et al. Feb 2017 A1
20170042742 Demayo Feb 2017 A1
20170049584 Pusch et al. Feb 2017 A1
20170049654 Demayo et al. Feb 2017 A1
20170056210 Jonasson et al. Mar 2017 A1
20170079811 Kelley et al. Mar 2017 A1
20170095354 Pusch et al. Apr 2017 A1
20170105853 Jonsson et al. Apr 2017 A1
20170112640 Clausen et al. Apr 2017 A1
20170119552 Clausen et al. May 2017 A1
20170119569 Hsu et al. May 2017 A1
20170135448 Ingimundarson et al. May 2017 A1
20170143519 Muller et al. May 2017 A1
20170151073 Halldorsson Jun 2017 A1
20170156893 Olafsson et al. Jun 2017 A1
20170156911 Ingimundarson et al. Jun 2017 A1
20170156963 Tuttemann et al. Jun 2017 A1
20170165095 Romo et al. Jun 2017 A1
20170189220 Ingimundarson et al. Jul 2017 A1
20170202687 Anhalt et al. Jul 2017 A1
20170231788 Kelley et al. Aug 2017 A1
20170231796 Romo et al. Aug 2017 A1
20170239118 Cole et al. Aug 2017 A1
20170246022 Calco et al. Aug 2017 A1
20170252198 Thorsteinsdottir et al. Sep 2017 A1
20170252249 Cole et al. Sep 2017 A1
20170254004 Rockstroh et al. Sep 2017 A1
20170266028 Thorgilsdottir et al. Sep 2017 A1
20170281373 Schober et al. Oct 2017 A1
20170281389 Frost et al. Oct 2017 A1
20170298981 Asgeirsson Oct 2017 A1
20170304081 Pusch et al. Oct 2017 A1
20170304083 Clausen Oct 2017 A1
20170304085 Kurth Oct 2017 A1
20170312158 Blackwell Nov 2017 A1
20170319286 Jansen et al. Nov 2017 A1
20170325974 Lincoln et al. Nov 2017 A1
20170325984 Walborn et al. Nov 2017 A1
20170333221 Lecomte et al. Nov 2017 A1
20170340469 Huffa et al. Nov 2017 A1
20170347904 Wilson Dec 2017 A1
20170348131 Petursson et al. Dec 2017 A1
20170360580 Karlsson et al. Dec 2017 A1
20170367851 Lincoln et al. Dec 2017 A1
20170367853 Dressler et al. Dec 2017 A1
20170367854 King Dec 2017 A1
20180000614 Shen Jan 2018 A1
20180000623 Ingimundarson et al. Jan 2018 A1
20180008436 Sandahl Jan 2018 A1
20180036149 Harris Feb 2018 A1
20180036151 Garus et al. Feb 2018 A1
20180036152 Klutts Feb 2018 A1
20180042654 Ingvarsson et al. Feb 2018 A1
20180042749 Ingimundarson Feb 2018 A1
20180042752 Omarsson et al. Feb 2018 A1
20180042754 Ingimundarson et al. Feb 2018 A1
20180049904 Ingimundarson et al. Feb 2018 A1
20180055659 Sandahl et al. Mar 2018 A1
20180055661 Erdmann et al. Mar 2018 A1
20180110642 Sorrenti et al. Apr 2018 A1
20180147080 Thorsteinsdottir et al. May 2018 A1
20180153715 Jonsson et al. Jun 2018 A1
20180177617 Pusch et al. Jun 2018 A1
20180177618 Langlois et al. Jun 2018 A1
20180185176 Jonsson et al. Jul 2018 A1
20180185186 Chetlapalli et al. Jul 2018 A1
20180193173 Sverrisson et al. Jul 2018 A1
20180200083 Egilsson et al. Jul 2018 A1
20180214284 Wagner et al. Aug 2018 A1
20180221176 Halldorsson et al. Aug 2018 A1
20180235784 Halldorsson et al. Aug 2018 A1
20180235785 Bache et al. Aug 2018 A1
20180256373 Birgisdottir et al. Sep 2018 A1
20180256380 Pusch et al. Sep 2018 A1
20180263793 Clausen et al. Sep 2018 A1
20180271678 Clausen Sep 2018 A1
20180271679 Caldwell et al. Sep 2018 A1
20180280183 Ingimundarson et al. Oct 2018 A1
20180281340 Brienza et al. Oct 2018 A1
20180289514 Chabloz et al. Oct 2018 A1
20180296370 Jonsson et al. Oct 2018 A1
20180296371 Jonasson et al. Oct 2018 A1
20180325212 Walborn et al. Nov 2018 A1
Foreign Referenced Citations (199)
Number Date Country
2030483 Mar 1984 AU
2003202173 Sep 2003 AU
2003202173 Sep 2007 AU
102012030461 Sep 2014 BR
102012030461 Sep 2014 BR
1309627 Nov 1992 CA
2042431 Nov 1992 CA
2042431 Nov 1992 CA
10309627 Nov 1992 CA
2108495 Apr 1995 CA
2108495 Apr 1995 CA
2174151 Jan 2000 CA
2290414 Aug 2004 CA
2237880 May 2006 CA
2864208 Aug 2014 CA
2864208 Aug 2014 CA
1146204 Mar 1997 CN
101257868 Sep 2008 CN
100536806 Sep 2009 CN
204562471 Aug 2015 CN
204839841 Dec 2015 CN
205758773 Dec 2016 CN
205866901 Jan 2017 CN
106798602 Jun 2017 CN
206299731 Jul 2017 CN
104394807 Aug 2017 CN
104394807 Aug 2017 CN
106667629 Apr 2018 CN
470581 Jan 1929 DE
1855981 Aug 1962 DE
1872483 May 1963 DE
2801299 Jun 1982 DE
2801299 Jun 1982 DE
7800863 Jan 1983 DE
7800863 Jan 1983 DE
59400260 Jun 1996 DE
59308220 Apr 1998 DE
59308220 Sep 1998 DE
29823435 Jul 1999 DE
29823435 Sep 1999 DE
19817445 Oct 1999 DE
19817445 Oct 1999 DE
59805657 Oct 2002 DE
59911786 Apr 2005 DE
10153796 Oct 2005 DE
10153796 Oct 2005 DE
10000495 Mar 2006 DE
10000495 Mar 2006 DE
10118101 May 2006 DE
10118101 May 2006 DE
202008014651 Jan 2009 DE
202008014651 Jan 2009 DE
202008014677 Jan 2009 DE
202008014677 Jan 2009 DE
102008058039 May 2010 DE
102008058039 May 2010 DE
202011001473 May 2011 DE
202011001473 Jun 2011 DE
102010020262 Dec 2011 DE
102010020262 Dec 2011 DE
202012001258 Mar 2012 DE
202012001258 Mar 2012 DE
102010045469 May 2012 DE
102010045469 May 2012 DE
102011105488 Dec 2012 DE
102011105488 Dec 2012 DE
102011119593 Dec 2013 DE
102011119593 Dec 2013 DE
59807695 Jan 2015 DE
59807695 Jan 2015 DE
10212011681 Apr 2015 DE
102012011681 Apr 2015 DE
102014113157 Feb 2016 DE
102014113157 Feb 2016 DE
102014116240 Jun 2016 DE
102014116240 Jun 2016 DE
102016107743 Oct 2017 DE
102016107743 Oct 2017 DE
102016111018 Dec 2017 DE
102016111018 Dec 2017 DE
102016118032 Jan 2018 DE
102016118032 Jan 2018 DE
0119231 Sep 1984 EP
0119231 Sep 1984 EP
0315675 Nov 1990 EP
0315675 Nov 1990 EP
0312515 May 1992 EP
0312515 May 1992 EP
0681818 Jul 2000 EP
0681818 Jul 2000 EP
1006960 Jan 2003 EP
1006960 Jan 2003 EP
0965435 Mar 2005 EP
0965435 Mar 2005 EP
1216013 Jun 2006 EP
1216013 Jun 2006 EP
1263356 Jan 2010 EP
1263356 Jan 2010 EP
1322267 Mar 2011 EP
1322267 Mar 2011 EP
1539057 Sep 2012 EP
1539057 Sep 2012 EP
0762857 Oct 2012 EP
0762857 Oct 2012 EP
2040649 Oct 2012 EP
2040649 Oct 2012 EP
1904773 Nov 2012 EP
1904773 Nov 2012 EP
2358268 Jul 2014 EP
2358268 Jul 2014 EP
2512387 Sep 2015 EP
2512387 Sep 2015 EP
2536366 Sep 2015 EP
2536366 Sep 2015 EP
2815728 Jan 2016 EP
2815728 Jan 2016 EP
2890295 Jun 2016 EP
2890295 Jun 2016 EP
1933775 Aug 2016 EP
1933775 Aug 2016 EP
2816978 Jan 2017 EP
2816978 Jan 2017 EP
3193794 Jul 2017 EP
3193794 Jul 2017 EP
3034044 Oct 2017 EP
3034044 Oct 2017 EP
3205221 Mar 2018 EP
3205221 Mar 2018 EP
3298991 Mar 2018 EP
3298991 Mar 2018 EP
3188697 Apr 2018 EP
3188697 Apr 2018 EP
3328327 Jun 2018 EP
3328327 Jun 2018 EP
235931 Mar 2011 ES
2353931 Mar 2011 ES
2345138 Apr 1982 FR
2345138 Apr 1982 FR
2012589 Aug 1979 GB
9922952 Dec 1999 GB
2353475 Feb 2001 GB
117003 Oct 2000 IL
198360 Jul 2009 IN
198360 Jul 2009 IN
H0822295 Mar 1996 JP
0822295 May 1996 JP
08131466 May 1996 JP
H08131466 May 1996 JP
2958257 Aug 2007 JP
3958257 Aug 2007 JP
4646318 Mar 2011 JP
4646319 Mar 2011 JP
100445086 Aug 2005 KR
100445086 Aug 2005 KR
101330740 Nov 2013 KR
101330740 Nov 2013 KR
101515254 Apr 2015 KR
101515254 Apr 2015 KR
1031419 Sep 2007 NL
1031419 Sep 2007 NL
315635 Jul 2003 NO
315635 Oct 2003 NO
434928 Aug 1984 SE
434928 Sep 1984 SE
8405072 Oct 1984 SE
469817 Sep 1993 SE
267100 Jan 1996 TW
343917 Nov 1998 TW
398902 Mar 2011 TW
M398902 Mar 2011 TW
9406375 Mar 1994 WO
9418863 Sep 1994 WO
9418863 Oct 1994 WO
9622864 Aug 1996 WO
9808470 Mar 1998 WO
9808470 May 1998 WO
0074611 Dec 2000 WO
0129120 Apr 2001 WO
0129128 Apr 2001 WO
0226158 Apr 2002 WO
2002026158 Apr 2002 WO
03034904 May 2004 WO
2004112663 Dec 2004 WO
2005102208 Nov 2005 WO
2009121615 Oct 2009 WO
2011029425 Mar 2011 WO
2012031707 Mar 2012 WO
2013124057 Aug 2013 WO
2014000066 Jan 2014 WO
2015169289 Nov 2015 WO
2016020244 Feb 2016 WO
2017147167 Aug 2017 WO
2017157875 Sep 2017 WO
2017162855 Sep 2017 WO
2017186680 Nov 2017 WO
2017186902 Nov 2017 WO
2017194479 Nov 2017 WO
2017216151 Dec 2017 WO
2018019637 Feb 2018 WO
Related Publications (1)
Number Date Country
20180360625 A1 Dec 2018 US
Provisional Applications (2)
Number Date Country
62550107 Aug 2017 US
62589025 Nov 2017 US
Continuations (7)
Number Date Country
Parent 14731818 Jun 2015 US
Child 14976129 US
Parent 13568535 Aug 2012 US
Child 14731818 US
Parent 16111569 US
Child 14731818 US
Parent 14731818 Jun 2015 US
Child 14976129 US
Parent 13568535 Aug 2012 US
Child 14731818 US
Parent 13568535 Aug 2012 US
Child 14731818 US
Parent 13642501 US
Child 14731771 US
Continuation in Parts (14)
Number Date Country
Parent 14976129 Dec 2015 US
Child 16111569 US
Parent 14976129 Dec 2015 US
Child 16111569 US
Parent PCT/US2011/033319 Apr 2011 US
Child 13568535 US
Parent 12799215 Apr 2010 US
Child PCT/US2011/033319 US
Parent 11901845 Sep 2007 US
Child 12799215 US
Parent 16111569 US
Child 12799215 US
Parent 14731818 Jun 2015 US
Child 16111569 US
Parent PCT/US2011/033319 Apr 2011 US
Child 13568535 US
Parent 12799215 Apr 2010 US
Child PCT/US2011/033319 US
Parent 11901845 Sep 2007 US
Child 12799215 US
Parent 16111569 US
Child 12799215 US
Parent 14731771 Jun 2015 US
Child 16111569 US
Parent 12799215 Apr 2010 US
Child 13642501 US
Parent 11901845 Sep 2007 US
Child 12799215 US